col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


158 Ergebisse       Seite 1

 [1] 
Elsevier: Virology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mai―14 Vectored long-term co-delivery of antibodies for SARS-CoV-2, RSV and Influenza prophylaxis Stine Sofie Frank Lende, Frederik Holm Rothemejer, Malthe Andreas, Maria Lange Pedersen, Laura Traberg-Nyborg, Emma Falling Iversen, et al. (+4)
2 [GO] 2025―Apr―25 Interference between SARS-CoV-2 and influenza B virus during coinfection is mediated by induction of specific interferon responses in the lung epithelium Dorothee Reuss, Jonathan C. Brown, Ksenia Sukhova, Wilhelm Furnon, Vanessa Cowton, Arvind H. Patel, et al. (+3)
3 [GO] 2025―Apr―12 A phycobiliprotein-based reporter assay for the evaluation of SARS-CoV-2 main protease activity Le Cao, Shuyuan Shi, Chaofeng Zhang, Cheng Zhao
4 [GO] 2025―Apr―09 Genetic diversity of canine coronavirus identified in dogs in Yulin city, southern China Chun-Yang Lian, Xin-Yan Yao, Zhi-Hang Lv, Xue-Lian Zhang, Jian-Wei Shao
5 [GO] 2025―Mrz―22 Translational research on pandemic virus infection using nonhuman primate models Hirohito Ishigaki, Yasushi Itoh
6 [GO] 2025―Mrz―22 Defining diverse Spike-Receptor interactions involved in SARS-CoV-2 entry: Mechanisms and Therapeutic Opportunities Michael Anderson, Julian Lopez, Maya Wyr, Peter W. Ramirez
7 [GO] 2025―Mrz―22 Multiple Exposures to SARS-CoV-2 Spike enhance Cross-Reactive Antibody-Dependent Cellular Cytotoxicity against SARS-CoV-1 Guillaume Beaudoin-Bussières, Alexandra Tauzin, Katrina Dionne, Omar El Ferri, Mehdi Benlarbi, Catherine Bourassa, et al. (+4)
8 [GO] 2025―Mrz―21 Recent SARS-CoV-2 evolution trajectories indicate the emergence of Omicron’s several subvariants and the current rise of KP.3.1.1 and XEC Chiranjib Chakraborty, Manojit Bhattacharya, Ali Saber Abdelhameed
9 [GO] 2025―Mrz―20 A Meta-Analysis on the Immunogenicity of Prototype, Monovalent-adapted and Bivalent vaccines against SARS-CoV-2 Wildtype, Omicron BA.1 and Omicron BA.4/5 in Healthy Adults. Jo-Lewis Banga Ndzouboukou, Abdul A. Kamara, Nadeem Ullah, Qing Lei, Xiong-lin Fan
10 [GO] 2025―Mrz―07 SARS-CoV-2 Nsp13 Helicase Modulates miR-146a-Mediated Signaling Pathways Eryn Lundrigan, Spencer Uguccioni, Christine Hum, Nadine Ahmed, John Paul Pezacki
11 [GO] 2025―Feb―25 Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon Mehdi Benlarbi, Dell-Dylan Kenfack, Katrina Dionne, Maxime Côté-Chenette, Guillaume Beaudoin-Bussières, Étienne Bélanger, et al. (+9)
12 [GO] 2025―Feb―21 Emergence, prevalence and evolution of porcine reproductive and respiratory syndrome virus 1 in China from 1994 to 2024 Yuejia Qiu, Ming Qiu, Shubin Li, Shubo Li, Jianzhong Zhu, Kegong Tian, Nanhua Chen
13 [GO] 2025―Feb―03 Intraspecific SARS-CoV-2 Delta Variant Transmission among Red Fox (Vulpes vulpes) and Striped Skunk (Mephitis mephitis) Stephanie M. Porter, Airn E. Hartwig, Marissa Quilici, Angela M. Bosco-Lauth, J. Jeffrey Root
14 [GO] 2025―Feb―01 Porcine epidemic diarrhea coronavirus infection activates caspase-8 to enhance innate immunity by blocking CYLD-mediated deubiquitination of RIG-I Huidi Yu, Linshan He, Xuemei Wu, Miao Zhang, Zhenhai Chen, Jing Sun, Xiulong Xu
15 [GO] 2025―Jan―27 Bats as a mixing vessel for generation of novel coronaviruses: Co-circulation and co-infection of coronaviruses and other viruses Antonio.C.P. Wong, Susanna.K.P. Lau, Patrick.C.Y. Woo
16 [GO] 2025―Jan―19 Towards developing multistrain PEDV vaccines: Integrating basic concepts and SARS-CoV-2 pan-sarbecovirus strategies Mario Fragoso-Saavedra, Qiang Liu
17 [GO] 2025―Jan―18 Current trends and future potential in the detection of avian coronaviruses: An emphasis on sensors-based technologies. Md. Safiul Alam Bhuiyan, Suman Das Gupta, Juplikely James Silip, Saranika Talukder, Md. Hakimul Haque, Jade K. Forwood, Subir Sarker
18 [GO] 2025―Jan―17 Structural Insights into Nucleocapsid Protein Variability: Implications for PJ34 Efficacy Against SARS-CoV-2 Akima Yamamoto, Haruki Ito, Takemasa Sakaguchi, Akifumi Higashiura
19 [GO] 2025―Jan―11 Antibody responses in Omicron BF.7-infected patients vaccinated with inactivated SARS-CoV-2 Yabo Zhao, Weili Li, Liming Xu, Zhanling Tao, Junhe Zhang
20 [GO] 2025―Jan―11 Transformative Approaches in SARS-CoV-2 Management: Vaccines, Therapeutics and Future Direction Ankita Saha, Shweta Choudhary, Priyanshu Walia, Pravindra Kumar, Shailly Tomar
21 [GO] 2025―Jan―10 Bat coronavirus surveillance across different habitats in Yucatán, México Marco Antonio Jiménez Rico, Ana Laura Vigueras-Galván, Erika Nayelli Hernández Villegas, Paola Martínez Duque, David Roiz, Luisa I. Falcón, et al. (+6)
22 [GO] 2025―Jan―07 Antiviral Mechanism of Fuzhengjiedu San against Porcine Reproductive and Respiratory Syndrome Virus Xin-Qi Song, Xin-Yi Zhao, Wen-Shuang Chen, Li Yang, Dong-Yu Liu, Ya-Ping Chen
23 [GO] 2025―Jan―06 Architects of infection: A structural overview of SARS-related coronavirus spike glycoproteins Francesca R. Hills, Jemma L. Geoghegan, Mihnea Bostina
24 [GO] 2024―Dez―25 Immunogenicity of a multivalent protein subunit vaccine based on non-glycosylated RBD antigens of SARS-cov-2 and its variants Berenice Calderón-Pérez, Leandro Alberto Núñez-Muñoz, Lady Laura Trejo-Ayala, Víctor Hugo Rosales-García, Benjamín Emmanuel Chávez-Álvarez, Brenda Yazmín Vargas-Hernández, et al. (+3)
25 [GO] 2024―Dez―22 Intra-host variability of SARS-CoV-2: Patterns, causes and impact on COVID-19 Leandro R. Jones
26 [GO] 2024―Dez―21 Host microRNAs as Regulators of Porcine Reproductive and Respiratory Syndrome Virus Infection Shu-yuan Guo, Wen-hai Feng
27 [GO] 2024―Dez―05 Exploring the role of carbon quantum dots as countermeasure for SARS-CoV-2 virus Kallol Roy, Binoy K. Saikia, Rituraj Konwar
28 [GO] 2024―Nov―29 The novel COVID-19 treatment VV116 is a potential inhibitor of Zika virus Shaokang Yang, Xiaotong Yang, Weiyan Zhu, Chongda Luo, Xintong Yan, Wei Li, et al. (+2)
29 [GO] 2024―Nov―29 Isolation and molecular characterization of an enteric isolate of the Genotype-Ia Bovine coronavirus with notable mutations in the receptor binding domain of the spike glycoprotein. Abid Shah, Phillip Gauger, Maged Gomaa Hemida
30 [GO] 2024―Nov―21 Research progress on the molecular mechanism of immune escape of porcine reproductive and respiratory syndrome virus Wenwen Hu, Deyuan Tang, Zhiyong Zeng, Bin Wang, Min Zhou, Yinming Mao, et al. (+2)
31 [GO] 2024―Nov―05 Strengths and limitations of SARS-CoV-2 virus-like particle systems Rokaia Sultana, Robert V. Stahelin
32 [GO] 2024―Nov―04 Genomic RNA Recombination of Porcine Reproductive and Respiratory Syndrome Virus and Other Arteriviruses Junyu Tang, Yu Fan Hung, Dongwan Yoo
33 [GO] 2024―Okt―18 The Ex Vivo Infection of the Peripheral Bovine Mononuclear Cells (PBMCs) and the Bovine Spleen Cells with the Bovine Coronavirus (BCoV) Induced a Differential Expression of the Host Cytokine Genes Profiles and Modulates the Virus Replication Abid Ullah Shah, Maged Gomaa Hemida
34 [GO] 2024―Okt―01 Biochemical simulation of mutation synthesis and repair during SARS-CoV-2 RNA polymerization Adrian Oo, Zhenhang Chen, Dongdong Cao, Young-Jae Cho, Bo Liang, Raymond F. Schinazi, Baek Kim
35 [GO] 2024―Sep―10 Receptor binding mechanism and immune evasion capacity of SARS-CoV-2 BQ.1.1 lineage Chenghai Wang, Yu Zhang, Chen Yang, Wenlin Ren, Chenguang Qiu, Shilong Fan, et al. (+2)
36 [GO] 2024―Sep―08 Control of nuclear localization of the nucleocapsid protein of SARS-CoV-2 Mengrui Wang, Maria Valadez-Ingersoll, Thomas D. Gilmore
37 [GO] 2024―Jul―23 Evidence that the SARS-CoV-2 S protein undergoes a conformational change at the Golgi Complex that leads to the formation of virus neutralising antibody binding epitopes in the S1 protein subunit. Yanjun Wu, Soak Kuan Lai, Conrad En-Zuo Chan, Boon Huan Tan, Richard J. Sugrue
38 [GO] 2024―Jul―03 The emergence, isolation, and phylogenetic analysis of a closely related human strain of parainfluenza virus 5 from a case of porcine reproductive and respiratory syndrome in China Jiaqi Liu, Tongwei Ren, Xindong Wang, Hao Wang, Guochang Chen, Yifeng Qin, et al. (+4)
39 [GO] 2024―Jul―02 Inactivation efficacy and mechanism of 9.375 GHz electromagnetic wave on coronavirus Yi Xiao, Hui Wang, Haoyu Wang, Ji Dong, Ruiyun Peng, Li Zhao
40 [GO] 2024―Jun―19 Peptide S4 is an entry inhibitor of SARS-CoV-2 infection Zhiyu Liang, Jiamei Wang, Huan Zhang, Lixia Gao, Jun Xu, Peiran Li, et al. (+7)
41 [GO] 2024―Mai―23 Humoral anti-SARS-CoV-2 response in patients with different long COVID phenotypes Piotr Rzymski, Jacek Niedziela, Barbara Poniedziałek, Joanna Rosińska, Dorota Zarębska-Michaluk, Barbara Sobala-Szczygieł, et al. (+3)
42 [GO] 2024―Mai―10 Identification of B-cell epitope on the N protein of Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) using Monoclonal Antibody and Construction of Epitope-mutated Virus Jiaqi Liu, Xindong Wang, Tongwei Ren, Jianguang Qin, Yifeng Qin, Kang Ouyang, et al. (+3)
43 [GO] 2024―Apr―26 Porcine reproductive and respiratory syndrome virus nsp4-mediated β2M downregulation contributes to SLA-I decrease and virus infection in vivo and in vitro Lei Kang, Abdul Wahaab, Pengfei Qi, Yafeng Qiu, Jianchao Wei, Beibei Li, et al. (+5)
44 [GO] 2024―Apr―08 Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication Shiori Ueno, Sodbayasgalan Amarbayasgalan, Yoshiro Sugiura, Tatsuki Takahashi, Kenta Shimizu, Keisuke Nakagawa, et al. (+2)
45 [GO] 2024―Apr―02 Porcine respiratory coronavirus genome sequences; comparisons and relationships to transmissible gastroenteritis viruses Amalie Ehlers Bedsted, Thomas Bruun Rasmussen, Laura D. Martinenghi, Anette Bøtner, Hans Nauwynck, Graham J. Belsham
46 [GO] 2024―Mrz―14 Increased expression of CD38 on endothelial cells in SARS-CoV-2 infection in cynomolgus macaque Cong Thanh Nguyen, Misako Nakayama, Hirohito Ishigaki, Yoshinori Kitagawa, Akemi Kakino, Marumi Ohno, et al. (+5)
47 [GO] 2024―Mrz―08 The investigation of the dynamics of changes in neutralizing antibody titers against type 5 adenovirus in the context of vaccination against a new coronavirus infection I.V. Amosova, T.A. Timoshicheva, R.A. Kadyrova, Y.A. Zabrodskaya, V.S. Vakin, M.P. Grudinin, et al. (+3)
48 [GO] 2024―Mrz―07 Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity Xiaotong Zheng, Rong Yang, Yuxiu Zhao, Yadan Zhang, Guangying Yuan, Weidong Li, et al. (+12)
49 [GO] 2024―Feb―27 Preliminary report on therapeutic potential of coal-derived carbon quantum dots against SARS-CoV-2 virus Binoy K. Saikia, Kallol Roy, Rituraj Konwar
50 [GO] 2024―Jan―28 A cell-adapted SARS-CoV-2 mutant, showing a deletion in the spike protein spanning the furin cleavage site, has reduced virulence at the lung level in K18-hACE2 mice. Fabrizia Valleriani, Chiara Di Pancrazio, Massimo Spedicato, Giovanni Di Teodoro, Daniela Malatesta, Tetyana Petrova, et al. (+14)
51 [GO] 2024―Jan―06 The leader RNA of SARS-CoV-2 sequesters polypyrimidine tract binding protein (PTBP1) and influences pre-mRNA splicing in infected cells Noelia H. Altina, David G. Maranon, John R. Anderson, Meghan K. Donaldson, Suad Elmegerhi, Laura A. St Clair, et al. (+3)
52 [GO] 2023―Nov―28 Avian coronavirus infectious bronchitis virus Beaudette strain NSP9 interacts with STAT1 and inhibits its phosphorylation to facilitate viral replication Ting Xia, Shengkui Xu, Xueyan Li, Wenke Ruan
53 [GO] 2023―Nov―28 Three distinct ORF1a recombinants of the SARS-CoV-2 Delta variant of concern Dong-Wook Lee, Jeong-Min Kim, Da-Won Kim, Ji-Yun Kim, Jeong-Ah Kim, Chae Young Lee, et al. (+5)
54 [GO] 2023―Nov―14 A potent neutralizing nanobody targeting a unique epitope on the receptor-binding domain of SARS-CoV-2 spike protein Yuting Zhang, Dan Wang, Qi Xiang, Xiaohui Hu, Yuting Zhang, Lijie Wu, et al. (+9)
55 [GO] 2023―Nov―07 Reassortant H9N2 canine influenza viruses containing the pandemic H1N1/2009 ribonucleoprotein complex circulating in pigs acquired enhanced virulence in mice Min Zhu, Hao Zeng, Jianqiao He, Yaohui Zhu, Pingping Wang, Jianing Guo, et al. (+7)
56 [GO] 2023―Nov―02 Identification of subgenomic mRNAs derived from the coronavirus 1a/1b protein gene: Implications for coronavirus transcription Ching-Hung Lin, Feng-Cheng Hsieh, Meilin Wang, Chieh Hsu, Hsuan-Wei Hsu, Chun-Chun Yang, et al. (+2)
57 [GO] 2023―Okt―31 Broad spectrum post-entry inhibitors of coronavirus replication: Cardiotonic steroids and monensin Shahrzad Jahanshahi, Hong Ouyang, Choudhary Ahmed, Ali Zahedi Amiri, Subha Dahal, Yu-Qian Mao, et al. (+12)
58 [GO] 2023―Okt―30 Analysis of spike and accessory 3c genes mutations of less virulent and FIP-associated feline coronaviruses in Beijing, China Jingru Zhu, Shuqi Deng, Danxia Mou, Gege Zhang, Yingying Fu, Wei Huang, et al. (+2)
59 [GO] 2023―Sep―29 RACK1 promotes porcine reproductive and respiratory syndrome virus infection in Marc-145 cells through ERK1/2 activation Xinxian Wang, Junlong Bi, Ying Yang, Lijun Li, Runting Zhang, Yongneng Li, et al. (+6)
60 [GO] 2023―Sep―25 An engineered A549 cell line expressing CD13 and TMPRSS2 is permissive to clinical isolate of human coronavirus 229E Laurensius Kevin Lie, Aleksandra Synowiec, Jedrzej Mazur, Lukasz Rabalski, Krzysztof Pyrć
61 [GO] 2023―Sep―18 Molecular insights into the SARS-CoV-2 Omicron variant from Bangladesh suggest diverse and continuous evolution Sultana Zahura Afrin, Fardousi Akter Sathi, Mohammed Nooruzzaman, Rokshana Parvin
62 [GO] 2023―Aug―26 Genomic epidemiology of SARS-CoV-2 variants in South Korea between January 2020 and February 2023 Il-Hwan Kim, Jin Sun No, Jeong-Ah Kim, Ae Kyung Park, HyeokJin Lee, Jeong-Min Kim, et al. (+7)
63 [GO] 2023―Aug―08 Molnupiravir, a ribonucleoside antiviral prodrug against SARS-CoV-2, alters the voltage-gated sodium current and causes adverse events Ai-Li Shiau, Kuan-Hsien Lee, Hsin-Yen Cho, Tzu-Hsien Chuang, Meng-Cheng Yu, Chao-Liang Wu, Sheng-Nan Wu
64 [GO] 2023―Aug―06 In silico screening of SARS-CoV2 helicase using African natural products: Docking and molecular dynamics approaches Hamada R. Knany, Sherif A. Elsabbagh, Moustafa A. Shehata, Wagdy M. Eldehna, Adnan A. Bekhit, Tamer M. Ibrahim
65 [GO] 2023―Jul―28 Physicochemical effects of emerging exchanges on the spike protein's RBM of the SARS-CoV-2 Omicron subvariants BA.1-BA.5 and its influence on the biological properties and attributes developed by these subvariants Robério Amorim de Almeida Pondé
66 [GO] 2023―Jul―24 Macro1 domain residue F156: A hallmark of SARS-cov-2 de-MARylation specificity Oney Ortega Granda, Karine Alvarez, Maria J. Mate-Perez, Bruno Canard, François Ferron, Nadia Rabah
67 [GO] 2023―Jul―24 Direct blue 53, a biological dye, inhibits SARS-CoV-2 infection by blocking ACE2 and spike interaction in vitro and in vivo Yu Xiao, Ling Wang, Shi-song Fang, Fan Luo, Shu-liang Chen, Lin Ye, Wei Hou
68 [GO] 2023―Jul―05 SARS-CoV-2 utilization of ACE2 from different bat species allows for virus entry and replication in vitro Kelsey Briggs, Ryan Sweeney, David S. Blehert, Erica Spackman, David L. Suarez, Darrell R. Kapczynski
69 [GO] 2023―Jun―15 A Trim-RBD-GEM vaccine candidate protects mice from SARS-CoV-2 Rina Su, Zhuangzhuang Shi, Entao Li, Menghan Zhu, Dongxu Li, Xiawei Liu, et al. (+7)
70 [GO] 2023―Jun―05 Emergence of SARS-CoV-2 serotype(s): Is it a matter of time? José Valter Joaquim Silva Júnior, Ricardo Durães-Carvalho, Joelma Rodrigues de Souza, Luiz Mário Ramos Janini, Rudi Weiblen, Eduardo Furtado Flores
71 [GO] 2023―Apr―18 The 3′UTR region of the DNA repair gene PARP-1 May increase the severity of COVID-19 by altering the binding of antiviral miRNAs Büşra Yilmaz, Güneş Çakmak Genç, Sevim Karakaş Çelik, Nihal Pişkin, Emre Horuz, Ahmet DURSUN
72 [GO] 2023―Apr―18 Stability of SARS-CoV-2 variants of concern (Delta and Omicron) on surfaces at room temperature Thomas Pottage, Okechukwu Onianwa, Barry Atkinson, Antony Spencer, Allan M. Bennett
73 [GO] 2023―Apr―05 Enhanced fitness of SARS-CoV-2 B.1.617.2 Delta variant in ferrets Xiangjie Sun, Jessica A. Belser, Troy J. Kieran, Nicole Brock, Joanna A. Pulit-Penaloza, Claudia Pappas, et al. (+6)
74 [GO] 2023―Mrz―16 Genomic characterization and molecular evolution of SARS-CoV-2 in Rio Grande do Sul State, Brazil Amanda de Menezes Mayer, Patrícia Aline Gröhs Ferrareze, Luiz Felipe Valter de Oliveira, Tatiana Schäffer Gregianini, Carla Lucia Andretta Moreira Neves, Gabriel Dickin Caldana, et al. (+2)
75 [GO] 2023―Mrz―10 Genetic conservation across SARS-CoV-2 non-structural proteins - Insights into possible targets for treatment of future viral outbreaks Shubhangi Kandwal, Darren Fayne
76 [GO] 2023―Feb―22 HnRNP K reduces viral gene expression by targeting cytosine-rich sequences in porcine reproductive and respiratory syndrome virus-2 genome to dampen the viral growth Huiyuan Jing, Yuzhen Song, Huawei Li, Erzhen Duan, Jie Liu, Wenting Ke, et al. (+8)
77 [GO] 2023―Jan―14 Application of codon pair deoptimization for ORF7-induced attenuation of type I porcine reproductive and respiratory syndrome virus without reduced immune responses Sang-Ho Cha, Su-Hwa You, Min-A Lee, Jong-Hyuk Baek, Sun-Hee Cho, Jiwoon Jeong, et al. (+3)
78 [GO] 2022―Dez―06 Long-term persistence of IgG antibodies in recovered COVID-19 individuals at 18 months post-infection and the impact of two-dose BNT162b2 (Pfizer-BioNTech) mRNA vaccination on the antibody response: Analysis using fixed-effects linear regression model Puya Dehgani-Mobaraki, Chao Wang, Alessandro Floridi, Emanuela Floridi, Sunny Dawoodi, Asiya K. Zaidi
79 [GO] 2022―Nov―28 Corrigendum to “A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination” [Virology 566 (2022) 56-59] Zhidong Hu, Jian-Ping Chen, Jin-Chuan Xu, Zhen-Yan Chen, Rong Qu, Ling Zhang, et al. (+6)
80 [GO] 2022―Nov―18 Exploring new antiviral targets for influenza and COVID-19: Mapping promising hot spots in viral RNA polymerases Inês Figueiredo-Nunes, João Trigueiro-Louro, Helena Rebelo-de-Andrade
81 [GO] 2022―Okt―07 Multi-target direct-acting SARS-CoV-2 antivirals against the nucleotide-binding pockets of virus-specific proteins Ruchi Rani, Siwen Long, Akshay Pareek, Preeti Dhaka, Ankur Singh, Pravindra Kumar, et al. (+2)
82 [GO] 2022―Sep―30 SARS-CoV-2 and influenza co-infection: A cross-sectional study in central Missouri during the 2021-2022 influenza season Cynthia Y. Tang, Maria Boftsi, Lindsay Staudt, Jane A. McElroy, Tao Li, Sabrina Duong, et al. (+5)
83 [GO] 2022―Sep―20 Development of a thermostable SARS-CoV-2 variant-based bivalent protein vaccine with cross-neutralizing potency against Omicron subvariants Rui Wang, Xun Huang, Tianshu Cao, Chunyun Sun, Dan Luo, Hongying Qiu, et al. (+15)
84 [GO] 2022―Sep―19 Faecal virome of the Australian grey-headed flying fox from urban/suburban environments contains novel coronaviruses, retroviruses and sapoviruses Kate Van Brussel, Jackie E. Mahar, Ayda Susana Ortiz-Baez, Maura Carrai, Derek Spielman, Wayne S.J. Boardman, et al. (+5)
85 [GO] 2022―Sep―07 Estimation of virus-mediated cell fusion rate of SARS-CoV-2 Ava Amidei, Hana M. Dobrovolny
86 [GO] 2022―Aug―27 Strain wars 4 - Darwinian evolution through Gibbs’ glasses: Gibbs energies of binding and growth explain evolution of SARS-CoV-2 from Hu-1 to BA.2 Marko Popovic
87 [GO] 2022―Aug―14 Transcriptomic analysis reveals crucial regulatory roles of immediate-early response genes and related signaling pathways in coronavirus infectious bronchitis virus infection Li Xia Yuan, Bei Yang, To Sing Fung, Rui Ai Chen, Ding Xiang Liu
88 [GO] 2022―Jul―31 Identification of CD163 regions that are required for porcine reproductive and respiratory syndrome virus (PRRSV) infection but not for binding to viral envelope glycoproteins Ana M.M. Stoian, Raymond R.R. Rowland, Alberto Brandariz-Nuñez
89 [GO] 2022―Jul―16 A robust high-throughput fluorescence polarization assay for rapid screening of SARS-CoV-2 papain-like protease inhibitors Haohao Yan, Zhicheng Liu, Gangan Yan, Xiaoli Liu, Xiaoping Liu, Yanchang Wang, Yunyu Chen
90 [GO] 2022―Jun―16 Potential linear B-cells epitope change to a helix structure in the spike of Omicron 21L or BA.2 predicts increased SARS-CoV-2 antibodies evasion Walid Al-Zyoud, Hazem Haddad
91 [GO] 2022―Jun―15 In-Silico targeting of SARS-CoV-2 NSP6 for drug and natural products repurposing Ahmed Abdelkader, Amal A. Elzemrany, Mennatullah El-Nadi, Sherif A. Elsabbagh, Moustafa A. Shehata, Wagdy M. Eldehna, et al. (+2)
92 [GO] 2022―Jun―10 Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein Heeji Lim, Se Eun Kim, Yun Ha Lee, Yun-Ho Hwang, Su Hwan Kim, Mi Young Kim, et al. (+4)
93 [GO] 2022―Mai―16 Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infection Prabhakaran Kumar, Manikannan Mathayan, Sandra P. Smieszek, Bartlomiej P. Przychodzen, Vuk Koprivica, Gunther Birznieks, et al. (+2)
94 [GO] 2022―Mai―12 Physicochemical effect of the N501Y, E484K/Q, K417N/T, L452R and T478K mutations on the SARS-CoV-2 spike protein RBD and its influence on agent fitness and on attributes developed by emerging variants of concern R.A.A. Pondé
95 [GO] 2022―Mai―10 Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant Kanwal Khan, Salman Ali Khan, Khurshid Jalal, Zaheer Ul-Haq, Reaz Uddin
96 [GO] 2022―Apr―12 Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E Yue Zhu, Frank Scholle, Samantha C. Kisthardt, De-Yu Xie
97 [GO] 2022―Mrz―29 Strain wars 2: Binding constants, enthalpies, entropies, Gibbs energies and rates of binding of SARS-CoV-2 variants Marko Popovic
98 [GO] 2022―Mrz―22 Pharmacophore based virtual screening for natural product database revealed possible inhibitors for SARS-COV-2 main protease Mohamed K. El-Ashrey, Riham O. Bakr, Marwa A.A. Fayed, Rana H. Refaey, Yassin M. Nissan
99 [GO] 2022―Mrz―07 Kappa-RBD produced by glycoengineered Pichia pastoris elicited high neutralizing antibody titers against pseudoviruses of SARS-CoV-2 variants Taotao Mi, Tiantian Wang, Huifang Xu, Peng Sun, Xuchen Hou, Xinwei Zhang, et al. (+5)
100 [GO] 2022―Feb―18 The interplay of viral loads, clinical presentation, and serological responses in SARS-CoV-2 - Results from a prospective cohort of outpatient COVID-19 cases Kerstin Puchinger, Noemi Castelletti, Raquel Rubio-Acero, Christof Geldmacher, Tabea M. Eser, Flora Deák, et al. (+110)
101 [GO] 2022―Feb―12 Development of an in vitro model for animal species susceptibility to SARS-CoV-2 replication based on expression of ACE2 and TMPRSS2 in avian cells Darrell R. Kapczynski, Ryan Sweeney, Erica Spackman, Mary Pantin-Jackwood, David L. Suarez
102 [GO] 2022―Feb―02 Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic Ezequiel G. Mogro, Daniela Bottero, Mauricio J. Lozano
103 [GO] 2022―Jan―17 SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway Huanzhou Xu, Ibukun A. Akinyemi, Siddhi A. Chitre, Julia C. Loeb, John A. Lednicky, Michael T. McIntosh, Sumita Bhaduri-McIntosh
104 [GO] 2021―Dez―14 Analysis of a crucial interaction between the coronavirus nucleocapsid protein and the major membrane-bound subunit of the viral replicase-transcriptase complex Cheri A. Koetzner, Kelley R. Hurst-Hess, Lili Kuo, Paul S. Masters
105 [GO] 2021―Dez―04 Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses Nadereh Naderi, Mahsa Rahimzadeh
106 [GO] 2021―Dez―01 A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination Zhidong Hu, Jian-Ping Chen, Jin-Chuan Xu, Zhen-Yan Chen, Rong Qu, Ling Zhang, et al. (+6)
107 [GO] 2021―Nov―27 Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro M.H. Raymonda, J.H. Ciesla, M. Monaghan, J. Leach, G. Asantewaa, L.A. Smorodintsev-Schiller, et al. (+6)
108 [GO] 2021―Nov―27 Microsecond simulations and CD spectroscopy reveals the intrinsically disordered nature of SARS-CoV-2 spike-C-terminal cytoplasmic tail (residues 1242-1273) in isolation Prateek Kumar, Taniya Bhardwaj, Neha Garg, Rajanish Giri
109 [GO] 2021―Okt―30 Swine acute diarrhea syndrome coronavirus replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway Jiyu Zhang, Liaoyuan Zhang, Hongyan Shi, Shufeng Feng, Tingshuai Feng, Jianfei Chen, et al. (+9)
110 [GO] 2021―Okt―22 Dynamics of SARS-CoV-2 variants of concern (VOC) in Bangladesh during the first half of 2021 Sultana Zahura Afrin, Md Taohidul Islam, Shyamal Kumar Paul, Nobumichi Kobayashi, Rokshana Parvin
111 [GO] 2021―Okt―04 Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses Yining Wang, Pengfei Li, Kundan Solanki, Yang Li, Zhongren Ma, Maikel P. Peppelenbosch, et al. (+2)
112 [GO] 2021―Sep―11 Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity Shang Yu Gong, Debashree Chatterjee, Jonathan Richard, Jérémie Prévost, Alexandra Tauzin, Romain Gasser, et al. (+8)
113 [GO] 2021―Sep―03 Adenovirus transduction to express human ACE2 causes obesity-specific morbidity in mice, impeding studies on the effect of host nutritional status on SARS-CoV-2 pathogenesis Pallavi Rai, Christina Chuong, Tanya LeRoith, James W. Smyth, Julia Panov, Moshe Levi, et al. (+3)
114 [GO] 2021―Aug―28 Upregulation of FOXP3 is associated with severity of hypoxia and poor outcomes in COVID-19 patients Ahmed S. Abdelhafiz, Mariam A. Fouad, Mohamed M. Sayed-Ahmed, Mahmoud M. Kamel, Asmaa Ali, Merhan Fouda, et al. (+3)
115 [GO] 2021―Jul―28 Prediction of two novel overlapping ORFs in the genome of SARS-CoV-2 Angelo Pavesi
116 [GO] 2021―Jul―23 SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung Lauren Byrd-Leotis, Yi Lasanajak, Thomas Bowen, Kelly Baker, Xuezheng Song, Mehul S. Suthar, et al. (+2)
117 [GO] 2021―Jun―28 Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants’ interaction with ACE2 to understand the binding affinity and stability Jyoti Verma, Naidu Subbarao
118 [GO] 2021―Jun―19 Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains Peyman Taghizadeh, Sadegh Salehi, Ali Heshmati, Seyed Massoud Houshmand, Kolsoum InanlooRahatloo, Forouzandeh Mahjoubi, et al. (+23)
119 [GO] 2021―Jun―18 Age- and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia Mihkel Plaas, Kadri Seppa, Nayana Gaur, Priit Kasenõmm, Mario Plaas
120 [GO] 2021―Mai―25 Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2 Shuai Ge, Jiayu Lu, Yajing Hou, Yuexin Lv, Cheng Wang, Huaizhen He
121 [GO] 2021―Mai―06 Frequency of HLA alleles among COVID-19 infected patients: Preliminary data from Saudi Arabia Fatmah M.A. Naemi, Shurooq Al-adwani, Heba Al-khattabi, Ashwaq Al-nazawi
122 [GO] 2021―Apr―21 Expression of SARS coronavirus 1 spike protein from a herpesviral vector induces innate immune signaling and neutralizing antibody responses Evelyn A. Kurt-Jones, Tim Dudek, Daisuke Watanabe, Leisa Mandell, Jenny Che, Shenghua Zhou, et al. (+8)
123 [GO] 2021―Mrz―19 The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein Xuemin Chen, Christina A. Rostad, Larry J. Anderson, He-ying Sun, Stacey A. Lapp, Kathy Stephens, et al. (+4)
124 [GO] 2021―Mrz―18 Conflicting and ambiguous names of overlapping ORFs in SARS-CoV-2: A homology-based resolution Irwin Jungreis, Chase W. Nelson, Zachary Ardern, Yaara Finkel, Nevan J. Krogan, Kei Sato, et al. (+6)
125 [GO] 2021―Mrz―05 Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India Kaustuv Nayak, Kamalvishnu Gottimukkala, Sanjeev Kumar, Elluri Seetharami Reddy, Venkata Viswanadh Edara, Robert Kauffman, et al. (+14)
126 [GO] 2021―Feb―26 On the road to ending the COVID-19 pandemic: Are we there yet? James Brett Case, Emma S. Winkler, John M. Errico, Michael S. Diamond
127 [GO] 2021―Feb―22 Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines Ahmed S. Abdel-Moneim, Elsayed M. Abdelwhab, Ziad A. Memish
128 [GO] 2021―Feb―22 Updating the influenza virus library at Hokkaido University -It's potential for the use of pandemic vaccine strain candidates and diagnosis Naoki Nomura, Keita Matsuno, Masashi Shingai, Marumi Ohno, Toshiki Sekiya, Ryosuke Omori, et al. (+3)
129 [GO] 2021―Feb―09 Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2 Teodora Djukic, Maja Mladenovic, Dragana Stanic-Vucinic, Jelena Radosavljevic, Katarina Smiljanic, Ljiljana Sabljic, et al. (+6)
130 [GO] 2021―Feb―04 Exploring the efficacy of naturally occurring biflavone based antioxidants towards the inhibition of the SARS-CoV-2 spike glycoprotein mediated membrane fusion Samiran Mondal, Abhijit Karmakar, Tamanna Mallick, Naznin Ara Begum
131 [GO] 2021―Feb―01 Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody James S. Terry, Loran BR. Anderson, Michael S. Scherman, Carley E. McAlister, Rushika Perera, Tony Schountz, Brian J. Geiss
132 [GO] 2021―Jan―26 Detecting SARS-CoV-2 3CLpro expression and activity using a polyclonal antiserum and a luciferase-based biosensor Amornrat O'Brien, Da-Yuan Chen, Matthew Hackbart, Brianna J. Close, Timothy E. O'Brien, Mohsan Saeed, Susan C. Baker
133 [GO] 2021―Jan―25 The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters Charles B. Stauft, Christopher Z. Lien, Prabhuanand Selvaraj, Shufeng Liu, Tony T. Wang
134 [GO] 2021―Jan―13 A novel ratio of CD8+:B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcome Maria G. Detsika, Kleio Ampelakiotou, Eirini Grigoriou, Katherina Psarra, Edison Jahaj, Charis Roussos, et al. (+4)
135 [GO] 2021―Jan―08 Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution Jeremy Ratcliff, Peter Simmonds
136 [GO] 2021―Jan―07 Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan Masaru Takeshita, Naoshi Nishina, Saya Moriyama, Yoshimasa Takahashi, Yoshifumi Uwamino, Mika Nagata, et al. (+9)
137 [GO] 2021―Jan―07 Corrigendum to “Analytical and clinical comparison of Viasure (CerTest Biotec) and 2019-nCoV CDC (IDT) RT-qPCR kits for SARS-CoV2 diagnosis” [Virology volume (2021) 154-156] Byron Freire-Paspuel, Patricio Vega-Marino, Alberto Velez, Marilyn Cruz, Franklin Perez, Miguel Angel Garcia-Bereguiain
138 [GO] 2020―Dez―30 Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs Shweta A. More, Akshay S. Patil, Nikhil S. Sakle, Santosh N. Mokale
139 [GO] 2020―Dez―29 Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques Hirohito Ishigaki, Misako Nakayama, Yoshinori Kitagawa, Cong Thanh Nguyen, Kaori Hayashi, Masanori Shiohara, et al. (+2)
140 [GO] 2020―Dez―25 Programmed -1 Ribosomal Frameshifting in coronaviruses: A therapeutic target Jamie A. Kelly, Michael T. Woodside, Jonathan D. Dinman
141 [GO] 2020―Dez―24 Coronavirus infection induces progressive restructuring of the endoplasmic reticulum involving the formation and degradation of double membrane vesicles Elaine M. Mihelc, Susan C. Baker, Jason K. Lanman
142 [GO] 2020―Dez―24 Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study Rana H. Refaey, Mohamed K. El-Ashrey, Yassin M. Nissan
143 [GO] 2020―Dez―16 Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2 Yongjing Zhang, Jue Wang, Shiling Hu, Zhuoyin Xue, Cheng Wang, Nan Wang
144 [GO] 2020―Nov―28 Effect of SARS-CoV-2 coinfection was not apparent on the dynamics of chronic hepatitis B infection Rentao Yu, Shun Tan, Yunjie Dan, Yanqiu Lu, Juan Zhang, Zhaoxia Tan, et al. (+7)
145 [GO] 2020―Nov―18 Analytical and clinical comparison of Viasure (CerTest Biotec) and 2019-nCoV CDC (IDT) RT-qPCR kits for SARS-CoV2 diagnosis. Byron Freire-Paspuel, Patricio Vega-Mariño, Alberto Velez, Marilyn Cruz, Franklin Perez, Miguel Angel Garcia-Bereguiain
146 [GO] 2020―Okt―31 Immunization with a recombinant fusion of porcine reproductive and respiratory syndrome virus modified GP5 and ferritin elicits enhanced protective immunity in pigs Hui Ma, Xiangmin Li, Jianglong Li, Zekai Zhao, Huawei Zhang, Genxi Hao, et al. (+2)
147 [GO] 2020―Okt―28 A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2 Rajarshi Bhattacharya, Aayatti Mallick Gupta, Suranjita Mitra, Sukhendu Mandal, Swadesh R. Biswas
148 [GO] 2020―Sep―28 Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients Linghua Li, Yuanhao Liang, Fengyu Hu, Huanchang Yan, Yueping Li, Zhiwei Xie, et al. (+7)
149 [GO] 2020―Sep―24 The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies Elahe Seyed Hosseini, Narjes Riahi Kashani, Hossein Nikzad, Javid Azadbakht, Hassan Hassani Bafrani, Hamed Haddad Kashani
150 [GO] 2020―Aug―26 Quantitative phylogenomic evidence reveals a spatially structured SARS-CoV-2 diversity Leandro R. Jones, Julieta M. Manrique
151 [GO] 2020―Aug―23 Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2 Hana M. Dobrovolny
152 [GO] 2020―Aug―20 Replicase 1a gene plays a critical role in pathogenesis of avian coronavirus infectious bronchitis virus Jing Zhao, Keran Zhang, Jinlong Cheng, Wenfeng Jia, Ye Zhao, Guozhong Zhang
153 [GO] 2020―Jul―29 A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) Tao Wu, Yiyue Ge, Kangchen Zhao, Xiaojuan Zhu, Yin Chen, Bin Wu, et al. (+3)
154 [GO] 2020―Jun―13 Growth, detection, quantification, and inactivation of SARS-CoV-2 James Brett Case, Adam L. Bailey, Arthur S. Kim, Rita E. Chen, Michael S. Diamond
155 [GO] 2020―Mai―25 Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series Negar Mohtadi, Abas Ghaysouri, Samira Shirazi, Elham Shafiee, Elham Bastani, Taleb Kokhazadeh, Hamed Tavan
156 [GO] 2020―Mai―19 The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells Hussin A. Rothan, Shannon Stone, Janhavi Natekar, Pratima Kumari, Komal Arora, Mukesh Kumar
157 [GO] 2020―Apr―30 Association of viral load with serum biomakers among COVID-19 cases Fengjuan Shi, Tao Wu, Xiaojuan Zhu, Yiyue Ge, Xiaoyan Zeng, Ying Chi, et al. (+6)
158 [GO] 2020―Feb―04 Hyper-phosphorylation of nsp2-related proteins of porcine reproductive and respiratory syndrome virus Pengcheng Shang, Fangfeng Yuan, Saurav Misra, Yanhua Li, Ying Fang
 [1] 

158 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec